The efficacy and safety of 4 cycles of tri-weekly nanoparticle albumin-bound paclitaxel (nab-PTX) followed by 4 cycles of FEC (5-fluorouracil, epirubicin, cyclophosphamide) as neoadjuvant chemotherapy for patients with HER2-negative primary breast cancer - A multicenter phase II study (KBCSG-TR1213)

被引：0

作者：

Tanaka, K. ^{[1
,11
]}

Masuda, N. ^{[1
,11
]}

Matsunami, N. ^{[2
]}

Takashima, T. ^{[3
]}

Morimoto, T. ^{[4
]}

Mizutani, M. ^{[1
,11
]}

Yoshidome, K. ^{[5
]}

Yasojima, H. ^{[1
,11
]}

Morishima, H. ^{[2
]}

Hata, K. ^{[6
]}

Shiba, E. ^{[7
]}

Tominaga, S. ^{[8
]}

Nishi, T. ^{[9
]}

Kamigaki, S. ^{[10
]}

Yoshinami, T.

Munakata, S. ^{[12
]}

Takeda, M. ^{[13
]}

Tsujimoto, M. ^{[14
]}

Nakayama, T. ^{[15
]}

机构：

[1] Natl Hosp Org Osaka Natioal Hosp, Surg Breat Oncol, Osaka, Japan

[2] Osaka Rosai Hosp, Breast Surg, Sakai, Osaka, Japan

[3] Osaka City Univ, Grad Sch Med, Surg Oncol, Osaka 558, Japan

[4] Yao Municipal Hosp, Breast Surg, Yao, Japan

[5] Osaka Police Hosp, Breast Surg, Osaka, Japan

[6] Kishiwada City Hosp, Surg Breast Oncol, Kishiwada, Japan

[7] Osaka Breast Clin, Breast Surg, Osaka, Japan

[8] Higashiosaka City Gen Hosp, Breast Surg, Higashiosaka, Osaka, Japan

[9] Kaizuka City Hosp, Breast Surg, Kaizuka, Japan

[10] Sakai City Med Ctr, Surg, Sakai, Osaka, Japan

[11] Osaka Med Ctr Canc & Cardiovasc Dis, Clin Oncol, Osaka, Japan

[12] Sakai City Med Ctr, Pathol, Sakai, Osaka, Japan

[13] Yao Municipal Hosp, Surg Pathol, Yao, Japan

[14] Osaka Police Hosp, Diagnost Pathol, Osaka, Japan

[15] Osaka Med Ctr Canc & Cardiovasc Dis, Breast & Endocrine Surg, Osaka, Japan

来源：

EUROPEAN JOURNAL OF CANCER | 2016年 / 57卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

333

引用

页码：S92 / S92

页数：1